07:43 AM EDT, 06/13/2024 (MT Newswires) -- Repligen ( RGEN ) said Thursday that Chief Executive Tony Hunt will become executive chair, and that it has promoted President and Chief Commercial Officer Olivier Loeillot to president and CEO.

Both moves are effective Sept. 1.

The life sciences company also said that Loeillot will join the Repligen Board, while current Chair Karen Dawes will become lead independent director.

Shares of the company were down 1.5% in recent premarket activity.

Price: 140.75, Change: -2.12, Percent Change: -1.48